Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
:BSX
Holding BSX?
Track your performance easily
BSX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$59.85 - $99.14
Previous CloseN/A
Volume5.49M
Average Volume (3M)4.91M
Market Cap
$144.69B
Enterprise Value$133.58B
Total Cash (Recent Filing)$196.00M
Total Debt (Recent Filing)$5.37B
Price to Earnings (P/E)81.6
Beta0.75
Next Earnings
Feb 05, 2025EPS Estimate
0.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.21
Shares Outstanding1,473,827,500
10 Day Avg. Volume5,684,878
30 Day Avg. Volume4,907,879
Standard Deviation0.06
R-Squared0.42
Alpha0.00433
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.09
Price to Cash Flow (P/CF)36.10
P/FCF Ratio41.20
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue8.40
Enterprise Value/Gross Profit13.50
Enterprise Value/Ebitda35.86
Forecast
1Y Price Target
$101.35Price Target Upside2.73% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering21
Boston Scientific News
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe ADVANTAGE AF trial results are generally seen as a win for Boston Scientific, aligning with investor expectations and demonstrating solid efficacy rates.
Market ExpansionBoston Scientific's global platform could accelerate IVL adoption outside the US, where penetration is currently low.
Strategic AcquisitionBoston Scientific announced that it had entered into an agreement to acquire Bolt Medical, marking its entry into the high-growth intravascular lithotripsy market.
Bears Say
Clinical TrialsThe future of the neo2 valve in the United States is uncertain, and it likely requires another trial to gain market approval due to safety concerns.
Growth ConcernsThere is a belief that BSX's organic growth may have reached a near-term peak, and there is concern that investors may increasingly worry about BSX's growth slowing as it laps its outstanding results and new PFA competitors enter the market.
Market ChallengesBSX faced challenges when Varipulse was temporarily pulled from the US market, as investors anticipated significant market share losses to competitors.
---
Ownership Overview
0.18% Insiders
30.01% Mutual Funds
0.29% Other Institutional Investors
49.38% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BSX FAQ
What was Boston Scientific’s price range in the past 12 months?
Boston Scientific lowest stock price was $59.85 and its highest was $99.14 in the past 12 months.
What is Boston Scientific’s market cap?
Boston Scientific’s market cap is $144.69B.
When is Boston Scientific’s upcoming earnings report date?
Boston Scientific’s upcoming earnings report date is Feb 05, 2025 which is in 15 days.
How were Boston Scientific’s earnings last quarter?
Boston Scientific released its earnings results on Oct 23, 2024. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.588 by $0.042.
Is Boston Scientific overvalued?
According to Wall Street analysts Boston Scientific’s price is currently Undervalued.
Does Boston Scientific pay dividends?
Boston Scientific does not currently pay dividends.
What is Boston Scientific’s EPS estimate?
Boston Scientific’s EPS estimate is 0.66.
How many shares outstanding does Boston Scientific have?
Boston Scientific has 1,473,827,500 shares outstanding.
What happened to Boston Scientific’s price movement after its last earnings report?
Boston Scientific reported an EPS of $0.63 in its last earnings report, beating expectations of $0.588. Following the earnings report the stock price went down -0.636%.
Which hedge fund is a major shareholder of Boston Scientific?
Among the largest hedge funds holding Boston Scientific’s share is PRIMECAP Management Co. It holds Boston Scientific’s shares valued at 3B.
---
Boston Scientific Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$101.35 (2.73% Upside)
$101.35 (2.73% Upside)
Blogger Sentiment
Bullish
BSX Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $446.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 17.3%
Last 30 Days ▲ 17.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.84%
12-Months-Change
Fundamentals
Return on Equity
9.05%
Trailing 12-Months
Asset Growth
11.85%
Trailing 12-Months
Company Description
Boston Scientific
Boston Scientific Corporation engages in the manufacturing of medical devices and products that are used in various interventional medical specialties worldwide. The company provides implantable devices including heart monitors, technologies for treating coronary artery disease and other cardiovascular disorders, and devices for diagnosing and treating gastrointestinal and pulmonary problems.
---
BSX Company Deck
---
BSX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Boston Scientific reported strong revenue and EPS growth, driven by standout performances in operational regions and the electrophysiology segment. However, there were challenges in the Neuromodulation segment and a temporary pause in the AVANT GUARD trial. Despite these issues, the company's financial outlook remains positive.Read More>---
BSX Revenue Breakdown
61.93% Cardiovascular
38.08% MedSurg
---
BSX Stock 12 Month Forecast
Average Price Target
$101.35
▲(2.73% Upside)
Technical Analysis
Medtronic
―
Stryker
―
Abbott Labs
―
Zimmer Biomet Holdings
―
Edwards Lifesciences
―
Intuitive Surgical
―
Best Analysts Covering BSX
1 Year
1 Year Success Rate
25/25 ratings generated profit
1 Year Average Return
+31.26%
reiterated a buy rating 6 days ago
Copying Shagun Singh Chadha's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +31.26% per trade.
---